NMN-C®

Our proprietary, high-purity form of NMN called NMN-C® has been developed over two years to deliver a pharmaceutical-grade form of NMN to consumers.

Undertaking research that delivers effective NAD+ boosters requires dedication to core scientific principles:

1. We determined the safe dosage of NMN uptake as a dietary supplement through an OECD408 toxicology study compliant with the FDA Dietary Supplement regulatory guidelines.

2. Our NMN-C® acquired self-affirmed GRAS (Generally Recognized as Safe) status in accordance with stringent US FDA regulatory guidelines in November 2020.

WORLD FIRST TOXICOLOGY STUDY*

A world first OECD 408 toxicology study was undertaken in 2020 on our NMN-C® in order to determine the safe dosage of NMN uptake as a dietary supplement.


The study – the first of its kind to be undertaken on NMN – analyzed the No Observable Adverse Effect Level (NOAEL) of NMN, with results showing NMN-C® to be an extremely well-tolerated option in comparison to other popular NAD+ boosters.


Results as been published February 12 2021.

 * Statement based on review of publications on PubMed as of January 1, 2021

VERIFIED SAFE

Our patented, high-purity NMN-C® acquired self-affirmed self GRAS (Generally Recognized as Safe) status in accordance with stringent US FDA regulatory guidelines.


Performed by an independent panel of toxicology and nutrition experts, the successful self-GRAS review is a major endorsement of the quality and integrity of our NMN.


Along with our cGMP-certified, pharmaceutical-grade manufacturing procedures it further verifies the safety of our NMN-C®.

PROPRIETARY MANUFACTURING

We maintain strict control over every element of our production and manufacturing process, which ensures that all our products deliver the highest levels of quality available in an NAD+ booster today.


Over two years we developed a manufacturing process in Europe that could be applied at a large enough scale to make high purity NMN affordable for consumers.

NMN-C®

Our proprietary high-purity form of NMN called NMN-C® 
has been developed over two years to deliver
a pharmaceutical-grade form of NMN to consumers.

Undertaking research that delivers effective NAD+ boosters requires dedication to core scientific principles :

1. We determined the safe dosage of NMN uptake as a dietary supplement through an OECD408 toxicology study compliant with the FDA Dietary Supplement regulatory guidelines.

2. Our NMN-C® acquired self-affirmed GRAS (Generally Recognized as Safe) status in accordance with stringent US FDA regulatory guidelines in November 2020.

WORLD FIRST TOXICOLOGY STUDY*

A world first OECD 408 toxicology study has been performed in 2020 on our NMN-C® in order to determine the safe dosage of NMN uptake as a dietary supplement.


The study – the first of its kind to be undertaken on NMN – analyzed the No Observable Adverse Effect Level (NOAEL) of NMN, with results showing NMN-C® to be an extremely well-tolerated option in comparison to other popular NAD+ boosters.


Results as been published February 12 2021.

 * Statement based on review of publications on PubMed as of January 1, 2021

VERIFIED SAFE

Our patented, high-purity NMN-C® acquired self-affirmed self GRAS (Generally Recognized as Safe) status in accordance with stringent US FDA regulatory guidelines.


Performed by an independent panel of toxicology and nutrition experts, the successful self-GRAS review is a major endorsement of the quality and integrity of our NMN.


Along with our cGMP-certified, pharmaceutical-grade manufacturing procedures it further verifies the safety of our NMN-C® .